Performed at only C-1801, C-1802, and C-1803 sites globally. No general public enrollment. Biogen Idec is located in is a clinical research site located in Cambridge, Massachusetts, United States 02142.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Performed at only C-1801, C-1802, and C-1803 sites globally. No general public enrollment. Biogen Idec is located in has participated in 1 clinical trials.
Therapeutic areas: Multiple Sclerosis.
Sponsors: Biogen.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Performed at only C-1801, C-1802, and C-1803 sites globally. No general public enrollment. Biogen Idec is located in has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Performed at only C-1801, C-1802, and C-1803 sites globally. No general public enrollment. Biogen Idec is located in has 1 clinical trials on record. Their work covers Multiple Sclerosis.
Performed at only C-1801, C-1802, and C-1803 sites globally. No general public enrollment. Biogen Idec is located in has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.